MX2019009350A - Producto de avena enriquecido con avenantramidas. - Google Patents

Producto de avena enriquecido con avenantramidas.

Info

Publication number
MX2019009350A
MX2019009350A MX2019009350A MX2019009350A MX2019009350A MX 2019009350 A MX2019009350 A MX 2019009350A MX 2019009350 A MX2019009350 A MX 2019009350A MX 2019009350 A MX2019009350 A MX 2019009350A MX 2019009350 A MX2019009350 A MX 2019009350A
Authority
MX
Mexico
Prior art keywords
avenanthramide
oat
oat product
enriched
enriched oat
Prior art date
Application number
MX2019009350A
Other languages
English (en)
Inventor
Chu Yifang
JOHNSON Jodee
Shi Yuhui
O'shea Marianne
Original Assignee
Quaker Oats Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quaker Oats Co filed Critical Quaker Oats Co
Publication of MX2019009350A publication Critical patent/MX2019009350A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/143Cereal granules or flakes to be cooked and eaten hot, e.g. oatmeal; Reformed rice products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Una composición y método para un producto a base avena enriquecido con avenantramidas que tiene efectos saludables mejorados. El producto a base avena incluye un ingrediente de avenantramida que tiene las avenantramidas 2c:2p:2f en relaciones proporcionales que comprenden por lo menos una de 1:1:1 y 1:2:2. De manera más particular, el ingrediente de avenantramida puede derivarse sintéticamente o recuperarse a partir del procesamiento de avenas en bruto a fracciones constituyentes de avena.
MX2019009350A 2014-05-21 2016-11-17 Producto de avena enriquecido con avenantramidas. MX2019009350A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14/284,101 US9826759B2 (en) 2014-05-21 2014-05-21 Avenanthramide-enriched oat product

Publications (1)

Publication Number Publication Date
MX2019009350A true MX2019009350A (es) 2019-10-02

Family

ID=54554783

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016015114A MX2016015114A (es) 2014-05-21 2015-05-21 Producto de avena enriquecido con avenatramidas.
MX2019009350A MX2019009350A (es) 2014-05-21 2016-11-17 Producto de avena enriquecido con avenantramidas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016015114A MX2016015114A (es) 2014-05-21 2015-05-21 Producto de avena enriquecido con avenatramidas.

Country Status (5)

Country Link
US (1) US9826759B2 (es)
EP (1) EP3145327A4 (es)
CA (1) CA2949553C (es)
MX (2) MX2016015114A (es)
WO (1) WO2015179676A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190350887A1 (en) * 2018-05-18 2019-11-21 The Quaker Oats Company INCREASING BIOAVAILABILITY OF IRON WITH AVENANTHRAMIDE 2c
EP3855934A2 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
JP2023518790A (ja) 2020-03-26 2023-05-08 ラントメネン・ファンクショナル・フーズ・アーベー 身体活動時の回復を促進するための麦芽穀類を含む消費可能な製品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067626A2 (en) 1999-05-06 2000-11-16 Ceapro Inc. Oat extracts: refining, compositions and methods of use
US20060100274A1 (en) * 2004-11-05 2006-05-11 Trustees Of Tufts College Therapeutic avenanthramide compounds
CA2704380A1 (en) 2007-11-08 2009-05-14 Ceapro Inc. Avenanthramide-containing compositions
US9504272B2 (en) 2008-11-04 2016-11-29 The Quaker Oats Company Method of processing oats to achieve oats with an increased avenanthramide content
AU2010228083B2 (en) * 2009-03-27 2014-05-22 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Method for increasing concentration of avenanthramides in oats
US9011947B2 (en) 2009-06-14 2015-04-21 The Quaker Oats Company Method of preparing highly dispersible whole grain flour with an increased avenanthramide content

Also Published As

Publication number Publication date
CA2949553A1 (en) 2015-11-26
EP3145327A4 (en) 2018-01-10
WO2015179676A1 (en) 2015-11-26
CA2949553C (en) 2019-03-05
MX2016015114A (es) 2017-02-22
US9826759B2 (en) 2017-11-28
US20150335045A1 (en) 2015-11-26
EP3145327A1 (en) 2017-03-29

Similar Documents

Publication Publication Date Title
AU365211S (en) Electronic cigarette component
EP3481434A4 (en) CRISPR / CAS9 COMPOSITIONS AND METHODS FOR TREATING RETINE DEGENERENCES
SA517381819B1 (ar) التعديل المناعي
IL268828A (en) products and vehicles
AU201715913S (en) Lid
AU201715912S (en) Lid
GB2576790B (en) Food product compositions and methods for producing the same
EP4299133A3 (en) Compositions and methods for the delivery of therapeutics
EP3122872A4 (en) Compositions and methods for treating type 1 and type 2 diabetes and related disorders
AU364536S (en) Confectionery package
IL269576A (en) products and vehicles
AU366532S (en) Electronic cigarette component
AU366529S (en) Electronic cigarette component
WO2016170124A3 (en) Nmda antagonists for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior
IL269517A (en) compounds and products
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
PH12018500994A1 (en) Nutritional compositions containing butyrate and uses thereof
AU201716493S (en) Lid
AU364242S (en) Confectionery packaging
AU201713895S (en) Lid
MX2019009350A (es) Producto de avena enriquecido con avenantramidas.
AU201714460S (en) Closure
EP3342784A4 (en) COMPLETELY HUMAN ANTIBODY WITH SPECIFIC INHIBITION OF CONNEXIN 26
EP3576728A4 (en) COMPOSITIONS AND METHODS TO INHIBIT THE RETICULON 4 INHIBITOR
WO2015108945A3 (en) Compositions and methods for the delivery of therapeutics